Treatment success rate: previously treated TB cases in Moldova
Moldova: Treatment success rate: previously treated TB cases was 61 in 2023. ▲ Rising
Treatment success rate: previously treated TB cases in Moldova, 2000–2023
Source: World Health Organization, Global Health Observatory.
Analysis
Moldova recorded 61 for treatment success rate: previously treated tb cases in 2023.
The figure is down 4.7% on the previous year and up 56.4% over ten years.
Over the whole period, treatment success rate: previously treated tb cases in Moldova peaked at 64 in 2022 and was at its lowest, 0, in 2000.
That places Moldova 114th out of 179 countries with data for 2023, putting it in the middle of the range.
The long-run direction has been consistently rising across the 24 years of available data.
Treatment success rate: previously treated TB cases in Moldova, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 0 | — |
| 2001 | 57 | — |
| 2002 | 37 | -35.1% |
| 2003 | 37 | +0.0% |
| 2004 | 38 | +2.7% |
| 2005 | 41 | +7.9% |
| 2006 | 43 | +4.9% |
| 2007 | 36 | -16.3% |
| 2008 | 34 | -5.6% |
| 2009 | 34 | +0.0% |
| 2010 | 32 | -5.9% |
| 2011 | 38 | +18.8% |
| 2012 | 39 | +2.6% |
| 2013 | 39 | +0.0% |
| 2014 | 47 | +20.5% |
| 2015 | 47 | +0.0% |
| 2016 | 44 | -6.4% |
| 2017 | 50 | +13.6% |
| 2018 | 47 | -6.0% |
| 2019 | 60 | +27.7% |
| 2020 | 58 | -3.3% |
| 2021 | 58 | +0.0% |
| 2022 | 64 | +10.3% |
| 2023 | 61 | -4.7% |
Moldova compared with similar countries
- Moldova's 61 is below the median for upper middle income countries, which is 63, 97% of the median. (54 countries reporting)
- Moldova's 61 is below the median for Europe & Central Asia, which is 69, 88% of the median. (47 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 35.7 | 0 | 57 | 10 |
| 2010s | 44.3 | 32 | 60 | 10 |
| 2020s | 60.25 | 58 | 64 | 4 |
Countries ranked near Moldova
- 113 Malaysia 62 compare
- 114 Equatorial Guinea 61 compare
- 114 Belgium 61 compare
- 114 Guinea-Bissau 61 compare
More health data for Moldova
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.2486 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,492 deaths per 1,000 people (2090)
- Number of infants who die before age 1 29 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -5.71 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.026 units per person (2025)
- Population ages 00-04, male, annual growth rate -5.57 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is treatment success rate: previously treated tb cases in Moldova?
- Treatment success rate: previously treated tb cases in Moldova was 61 in 2023, according to World Health Organization, Global Health Observatory.
- What is the highest treatment success rate: previously treated tb cases recorded in Moldova?
- The highest recorded value was 64 in 2022.
- What is the lowest treatment success rate: previously treated tb cases recorded in Moldova?
- The lowest recorded value was 0 in 2000.
- How does Moldova rank for treatment success rate: previously treated tb cases?
- Moldova ranks 114th out of 179 countries with data for 2023.
- Is treatment success rate: previously treated tb cases rising or falling in Moldova?
- Over the last ten years it is up 56.4%. The long-run trend across the full record is rising.
- Where does this Moldova data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Treatment success rate: previously treated TB cases. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 24 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).